1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021, Due to Increasing Prevalence of Fungal Toe Nail Infections

Dermatophytic onychomycosis is a fungal nail infection caused by dermatophytes. Dermatophytic onychomycosis is also known as tinea unguium. It is called the dermatophytic invasion of the nail plate. It is the most common nail infection and constitutes more than half of all nail disease cases. This condition mostly affects toenails. The overall prevalence rate of dermatophytic onychomycosis is around 10% in the general population. The disease can lead to severe pain and can impede work and social activities.

This report covers the global dermatophytic onychomycosis therapeutics market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global dermatophytic onychomycosis therapeutics market. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to better equip clients with crystal clear decision-making insights.

The global dermatophytic onychomycosis therapeutics market is mainly driven by factors such as increasing the prevalence of dermatophytic onychomycosis, rising aging population, increasing consumer inclination towards maintaining aesthetic appearance of nails, and increasing per capita healthcare expenditure. Potential side effects of therapeutic products, availability of alternative treatments, and lack of awareness in emerging regions such as APEJ and MEA are expected to hinder the growth of the dermatophytic onychomycosis therapeutics market.

On the basis of products, dermatophytic onychomycosis therapeutics market is segmented into tablet and nail paint. Both the segments, tablet and nail paint are further sub-segmented into prescription and over-the-counter products. By distribution channel, dermatophytic onychomycosis therapeutics market is segmented into hospitals, clinics, independent pharmacies, mail order pharmacies, and drug stores.

By product, revenue from the tablet segment is projected to rise at the highest CAGR of 5.2% during the forecast period. The nail paint segment is expected to dominate the market, accounting for a maximum share of the overall market by 2021. The nail paint segment revenue is projected to rise at a CAGR of 8.3% during the forecast period (2015–2021).

By treatment, the topical segment is estimated to dominate the dermatophytic onychomycosis therapeutics market, accounting for a maximum share of the overall market by 2015 end. Revenue from the topical segment is projected to increase at a CAGR of 8.3% during the forecast period.

In terms of value, North America dominated the market with over 43% market share in 2014, followed by Europe. In Asia Pacific, this market is projected to expand at the highest CAGR of 5.1% during the forecast period.

Key players of the global dermatophytic onychomycosis therapeutics market are Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc. Leading players operating in the market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.

The dermatophytic onychomycosis therapeutics market is segmented as follows:

By Product:
Tablet
Prescription (Rx.)
Over-the-counter
Nail Paint
Prescription (Rx.)
Over-the-counter
By Treatment:
Oral
Topical
By Distribution Channels:
Hospitals
Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores
By Region:
North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Rest of Europe
Asia pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
MEA
GCC Nations
South Africa
Rest of MEA

Key features included in this report:
Drivers and restraints of the dermatophytic onychomycosis therapeutics market
Latest product innovations and key developments in the market
Analysis of business strategies of the top players
Dermatophytic onychomycosis therapeutics market estimates and forecasts

Table Of Contents

Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021, Due to Increasing Prevalence of Fungal Toe Nail Infections
1. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Dermatophytic Onychomycosis Therapeutics Market Overview
4.1. Introduction
4.1.1. Dermatophytic Onychomycosis Therapeutics Market Definition
4.1.2. Dermatophytic Onychomycosis Therapeutics Market Taxonomy
4.1.3. Dermatophytic Onychomycosis Therapeutics Market Parent Overview
4.2. Dermatophytic Onychomycosis Therapeutics Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.2.4. Trends

5. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Product Type
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Product Type
5.1.2. Market Share and Basis Point (BPS) Analysis, By Product Type
5.2. Market Forecast, By Product Type
5.2.1. Tablet
5.2.1.1. Market Size Forecast and Y-o-Y Growth
5.2.1.2. Absolute $ Opportunity
5.2.1.3. Rx. Tablet
5.2.1.3.1. Market Size Forecast and Y-o-Y Growth
5.2.1.3.2. Absolute $ Opportunity
5.2.1.4. OTC Tablet
5.2.1.4.1. Market Size Forecast and Y-o-Y Growth
5.2.1.4.2. Absolute $ Opportunity
5.2.2. Nail Paint
5.2.2.1. Market Size Forecast and Y-o-Y Growth
5.2.2.2. Absolute $ Opportunity
5.2.2.3. Rx. Nail Paint
5.2.2.3.1. Market Size Forecast and Y-o-Y Growth
5.2.2.3.2. Absolute $ Opportunity
5.2.2.4. OTC Nail Paint
5.2.2.4.1. Market Size Forecast and Y-o-Y Growth
5.2.2.4.2. Absolute $ Opportunity
5.3. Market Attractiveness Analysis, By Product Type

6. Global Market Analysis, By Treatment Type
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Treatment Type
6.1.2. Market Share and Basis Point (BPS) Analysis, By Treatment Type
6.2. Market Forecast, By Treatment Type
6.2.1. Oral Therapy
6.2.1.1. Market Size Forecast and Y-o-Y Growth
6.2.1.2. Absolute $ Opportunity
6.2.2. Topical Therapy
6.2.2.1. Market Size Forecast and Y-o-Y Growth
6.2.2.2. Absolute $ Opportunity
6.3. Market Attractiveness Analysis, By Treatment Type
6.4. Prominent Trends

7. Global Market Analysis, By Distribution Channels
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Distribution Channels
7.1.2. Market Share and Basis Point (BPS) Analysis, By Distribution Channels
7.2. Market Forecast, By Distribution Channels
7.2.1. Hospital
7.2.1.1. Market Size Forecast and Y-o-Y Growth
7.2.1.2. Absolute $ Opportunity
7.2.2. Clinics
7.2.2.1. Market Size Forecast and Y-o-Y Growth
7.2.2.2. Absolute $ Opportunity
7.2.3. Independent Pharmacy
7.2.3.1. Market Size Forecast and Y-o-Y Growth
7.2.3.2. Absolute $ Opportunity
7.2.4. Mail Order Pharmacies
7.2.4.1. Market Size Forecast and Y-o-Y Growth
7.2.4.2. Absolute $ Opportunity
7.2.5. Drug Stores
7.2.5.1. Market Size Forecast and Y-o-Y Growth
7.2.5.2. Absolute $ Opportunity
7.3. Market Attractiveness Analysis, By Distribution Channels

8. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share and Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Forecast
8.2.2. Europe Market Forecast
8.2.3. APAC Market Forecast
8.2.4. Latin America Market Forecast
8.2.5. MEA Market Forecast
8.3. Regional Attractiveness Analysis, By Region

9. North America Market Value Forecast
9.1. Key Trends
9.2. Market Value Forecast, By Country
9.2.1. US Absolute $ Opportunity
9.2.2. Canada Absolute $ Opportunity
9.3. Market Value Forecast, By Product Type
9.3.1. Tablet
9.3.1.1. Rx. Tablet
9.3.1.2. OTC Tablet
9.3.2. Nail Paint
9.3.2.1. Rx. Nail Paint
9.3.2.2. OTC Nail Paint
9.4. Market Value Forecast, By Treatment Type
9.4.1. Oral Therapy
9.4.2. Topical Therapy
9.5. Market Value Forecast, By Distribution Channels
9.5.1. Hospital
9.5.2. Clinics
9.5.3. Independent Pharmacy
9.5.4. Mail Order Pharmacies
9.5.5. Drug Stores
9.6. Drivers and Restraints: Impact Analysis

10. Europe Market Value Forecast
10.1. Key Trends
10.2. Market Value Forecast, By Country
10.2.1. Germany Absolute $ Opportunity
10.2.2. Italy Absolute $ Opportunity
10.2.3. France Absolute $ Opportunity
10.2.4. The United Kingdom Absolute $ Opportunity
10.2.5. Spain Absolute $ Opportunity
10.2.6. Russia Absolute $ Opportunity
10.2.7. Rest of Europe Absolute $ Opportunity
10.3. Market Value Forecast, By Product Type
10.3.1. Tablet
10.3.1.1. Rx. Tablet
10.3.1.2. OTC Tablet
10.3.2. Nail Paint
10.3.2.1. Rx. Nail Paint
10.3.2.2. OTC Nail Paint
10.4. Market Value Forecast, By Treatment Type
10.4.1. Oral Therapy
10.4.2. Topical Therapy
10.5. Market Value Forecast, By Distribution Channels
10.5.1. Hospital
10.5.2. Clinics
10.5.3. Independent Pharmacy
10.5.4. Mail Order Pharmacies
10.5.5. Drug Stores
10.6. Drivers and Restraints: Impact Analysis

11. APAC Market Value Forecast
11.1. Key Trends
11.2. Market Value Forecast, By Country
11.2.1. Greater China Absolute $ Opportunity
11.2.2. Japan Absolute $ Opportunity
11.2.3. India Absolute $ Opportunity
11.2.4. Rest of APEJ Absolute $ Opportunity
11.3. Market Value Forecast, By Product Type
11.3.1. Tablet
11.3.1.1. Rx. Tablet
11.3.1.2. OTC Tablet
11.3.2. Nail Paint
11.3.2.1. Rx. Nail Paint
11.3.2.2. OTC Nail Paint
11.4. Market Value Forecast, By Treatment Type
11.4.1. Oral Therapy
11.4.2. Topical Therapy
11.5. Market Value Forecast, By Distribution Channels
11.5.1. Hospital
11.5.2. Clinics
11.5.3. Independent Pharmacy
11.5.4. Mail Order Pharmacies
11.5.5. Drug Stores
11.6. Drivers and Restraints: Impact Analysis

12. Latin America Market Value Forecast
12.1. Key Trends
12.2. Market Value Forecast, By Country
12.2.1. Argentina Absolute $ Opportunity
12.2.2. Brazil Absolute $ Opportunity
12.2.3. Mexico Absolute $ Opportunity
12.2.4. Rest of Latin America Absolute $ Opportunity
12.3. Market Value Forecast, By Product Type
12.3.1. Tablet
12.3.1.1. Rx. Tablet
12.3.1.2. OTC Tablet
12.3.2. Nail Paint
12.3.2.1. Rx. Nail Paint
12.3.2.2. OTC Nail Paint
12.4. Market Value Forecast, By Treatment Type
12.4.1. Oral Therapy
12.4.2. Topical Therapy
12.5. Market Value Forecast, By Distribution Channels
12.5.1. Hospital
12.5.2. Clinics
12.5.3. Independent Pharmacy
12.5.4. Mail Order Pharmacies
12.5.5. Drug Stores
12.6. Drivers and Restraints: Impact Analysis

13. MEA Market Value Forecast
13.1. Key Trends
13.2. Market Value Forecast, By Country
13.2.1. GCC Absolute $ Opportunity
13.2.2. South Africa Absolute $ Opportunity
13.2.3. Rest of MEA Absolute $ Opportunity
13.3. Market Value Forecast, By Product Type
13.3.1. Tablet
13.3.1.1. Rx. Tablet
13.3.1.2. OTC Tablet
13.3.2. Nail Paint
13.3.2.1. Rx. Nail Paint
13.3.2.2. OTC Nail Paint
13.4. Market Value Forecast, By Treatment Type
13.4.1. Oral Therapy
13.4.2. Topical Therapy
13.5. Market Value Forecast, By Distribution Channels
13.5.1. Hospital
13.5.2. Clinics
13.5.3. Independent Pharmacy
13.5.4. Mail Order Pharmacies
13.5.5. Drug Stores
13.6. Drivers and Restraints: Impact Analysis

14. Competition Landscape
14.1. Brand Share Analysis
14.2. Company Profiles
14.2.1. Revenue
14.2.2. Product Types/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Highlights
14.3.1. Valeant Pharmaceuticals International Inc.
14.3.2. Galderma S.A.
14.3.3. Novartis AG
14.3.4. Pfizer Inc.
14.3.5. Moberg Pharma AB
14.3.6. Janssen Global Services, LLC (Johnson and Johnson Services, Inc.)
14.3.7. Anacor Pharmaceuticals, Inc.

List of Tables

Table 01: Global Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Region, 2014-2021 (US$ Mn)
Table 02: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014-2021 (US$ Mn)
Table 03: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014-2021 (US$ Mn)
Table 04: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014-2021 (US$ Mn)
Table 05: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014-2021 (US$ Mn)
Table 06: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014-2021 (US$ Mn)
Table 07: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014-2021 (US$ Mn)
Table 08: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014-2021 (US$ Mn)
Table 09: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014-2021 (US$ Mn)
Table 10: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014-2021 (US$ Mn)
Table 11: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014-2021 (US$ Mn)
Table 12: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014-2021 (US$ Mn)
Table 13: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014-2021 (US$ Mn)
Table 14: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014-2021 (US$ Mn)
Table 15: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014-2021 (US$ Mn)
Table 16: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014-2021 (US$ Mn)

List of Figures

Figure 01: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%), 2014-2021
Figure 02: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity, 2014-2021
Figure 03: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 04: Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 05: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Tablet Segment, 2014-2021
Figure 06: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Tablet Segment, 2014-2021
Figure 07: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Rx. Tablet Sub-segment, 2014-2021
Figure 08: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Rx. Tablet Sub-segment, 2014-2021
Figure 09: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for OTC Tablet Sub-segment, 2014-2021
Figure 10: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for OTC Tablet Sub-segment, 2014-2021
Figure 11: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Nail Paint Segment, 2014-2021
Figure 12: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Nail Paint Segment, 2014-2021
Figure 13: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Rx. Nail Paint Sub-segment, 2014-2021
Figure 14: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Rx. Nail Paint Sub-segment, 2014-2021
Figure 15: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for OTC Nail Paint Sub-segment, 2014-2021
Figure 16: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for OTC Nail Paint Sub-segment, 2014-2021
Figure 17: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 18: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Treatment Type, 2015-2021
Figure 19: Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Treatment Type, 2014 and 2021
Figure 20: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Oral Segment, 2014-2021
Figure 21: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Oral Segment, 2014-2021
Figure 22: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Topical Segment, 2014-2021
Figure 23: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Topical Segment, 2014-2021
Figure 24: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2015-2021
Figure 25: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Distribution Channels, 2015-2021
Figure 26: Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Distribution Channels, 2014 and 2021
Figure 27: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Hospitals, 2014-2021
Figure 28: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Hospitals, 2014-2021
Figure 29: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Clinics, 2014-2021
Figure 30: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Clinics, 2014-2021
Figure 31: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Independent Pharmacies, 2014-2021
Figure 32: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Independent Pharmacies, 2014-2021
Figure 33: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Mail Order Pharmacies, 2014-2021
Figure 34: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Mail Order Pharmacies, 2014-2021
Figure 35: Global Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) for Drug Stores, 2014-2021
Figure 36: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Drug Stores, 2014-2021
Figure 37: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015-2021
Figure 38: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Region, 2015-2021
Figure 39: Global Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Region, 2014 and 2021
Figure 40: Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by North America, 2014-2021
Figure 41: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by North America, 2014-2021
Figure 42: Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Europe, 2014-2021
Figure 43: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Europe, 2014-2021
Figure 44: Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Asia Pacific, 2014-2021
Figure 45: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Asia Pacific, 2014-2021
Figure 46: Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Latin America, 2014-2021
Figure 47: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Latin America, 2014-2021
Figure 48: Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Middle East and Africa, 2014-2021
Figure 49: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Middle East and Africa, 2014-2021
Figure 50: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Region, 2015-2021
Figure 51: North America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 52: North America Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 53: North America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by U.S., 2014-2021
Figure 54: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by U.S., 2014-2021
Figure 55: North America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Canada, 2014-2021
Figure 56: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Canada, 2014-2021
Figure 57: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 58: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015-2021
Figure 59: Europe Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 60: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 61: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Germany, 2014-2021
Figure 62: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Germany, 2014-2021
Figure 63: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by France, 2014-2021
Figure 64: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by France, 2014-2021
Figure 65: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by U.K., 2014-2021
Figure 66: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by U.K., 2014-2021
Figure 67: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Italy, 2014-2021
Figure 68: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Italy, 2014-2021
Figure 69: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Spain, 2014-2021
Figure 70: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Spain, 2014-2021
Figure 71: Europe Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Rest of Europe, 2014-2021
Figure 72: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Europe, 2014-2021
Figure 73: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 74: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015-2021
Figure 75: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 76: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 77: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Japan, 2014-2021
Figure 78: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Japan, 2014-2021
Figure 79: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by China, 2014-2021
Figure 80: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by China, 2014-2021
Figure 81: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by India, 2014-2021
Figure 82: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by India, 2014-2021
Figure 83: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Australia and New Zealand, 2014-2021
Figure 84: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Australia and New Zealand, 2014-2021
Figure 85: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Rest of Asia Pacific, 2014-2021
Figure 86: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Asia Pacific, 2014-2021
Figure 87: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 88: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015-2021
Figure 89: Latin America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 90: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 91: Latin America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Brazil, 2014-2021
Figure 92: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Brazil, 2014-2021
Figure 93: Latin America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Mexico, 2014-2021
Figure 94: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Mexico, 2014-2021
Figure 95: Latin America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Argentina, 2014-2021
Figure 96: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Argentina, 2014-2021
Figure 97: Latin America Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Rest of Latin America, 2014-2021
Figure 98: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Latin America, 2014-2021
Figure 99: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 100: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015-2021
Figure 101: MEA Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014-2021
Figure 102: Middle East Dermatophytic Onychomycosis Therapeutics Market Value Share and BPS Analysis By Product Type, 2014 and 2021
Figure 103: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by GCC, 2014-2021
Figure 104: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by GCC, 2014-2021
Figure 105: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by South Africa, 2014-2021
Figure 106: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by South Africa, 2014-2021
Figure 107: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value and Y-o-Y Growth (%) by Rest of MEA, 2014-2021
Figure 108: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of MEA, 2014-2021
Figure 109: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015-2021
Figure 110: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015-2021

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Anti-Fungal Drugs Market - Growth, Trends and Forecast (2016 - 2021)

Global Anti-Fungal Drugs Market - Growth, Trends and Forecast (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global Anti-Fungal drugs market accounted for a market value of USD XX million in 2015 and is expected to reach USD XX million by 2016. The market is expected to reach USD XX million by 2021, growing ...

Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

The global antifungal agents market was estimated to grow around $10,200 million and it is expected to experience robust growth during 2016-2022.Antifungal agent is basically a drug which helps in detecting ...

Global Antifungal Agents Market Report 2016

Global Antifungal Agents Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Antifungal Agents Report is a professional and in-depth research report on the world's major regional market conditions of the Antifungal Agents industry, focusing on the main regions (North ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry in the US

  • November 2016
    52 pages
  • United States  

View report >

Global Livestock Industry

  • September 2016
    4 pages
  • Livestock  

    Antiseptics  

    Food  

  • World  

    Sweden  

View report >

Therapy Market in New Zealand

  • July 2016
    24 pages
  • Therapy  

    Anti-Infective  

    Antifungal  

  • New Zealand  

View report >

Otc Markets In The Us

8 months ago

Otc Industry In Canada

11 months ago

Related Market Segments :

Antifungal

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.